E

Diagnos Inc. ADK.V

TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Diagnos Inc. is a Canada‑based medical technology company operating in the healthcare diagnostics and digital health industries. The company focuses on the early detection and screening of eye diseases, particularly those related to retinal health, using advanced image analysis and artificial intelligence. Diagnos’ core value proposition is improving access to preventative eye care while reducing costs and clinical burden through automated diagnostic support tools.

The company’s primary revenue driver is its proprietary CARA retinal analysis platform, which analyzes retinal images to identify risk indicators for conditions such as diabetic retinopathy and age‑related macular degeneration. Diagnos serves eye care professionals, clinics, hospitals, and public health screening programs, with a strategic emphasis on large‑scale population screening. Founded in the late 1990s, the company originally focused on hardware‑based ophthalmic imaging and progressively evolved toward software‑driven, AI‑enabled diagnostics, aligning its strategy with the growing demand for scalable tele‑ophthalmology solutions.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, June 11, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
(est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
450 678 8882
Address
7005 Taschereau Boulevard
Suite 265
Brossard, QC J4Z 1A7
Country
Year Founded

Headlines

There are no news to display.